JP2025510945A5 - - Google Patents
Info
- Publication number
- JP2025510945A5 JP2025510945A5 JP2024557461A JP2024557461A JP2025510945A5 JP 2025510945 A5 JP2025510945 A5 JP 2025510945A5 JP 2024557461 A JP2024557461 A JP 2024557461A JP 2024557461 A JP2024557461 A JP 2024557461A JP 2025510945 A5 JP2025510945 A5 JP 2025510945A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- optionally substituted
- independently
- iii
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/084377 | 2022-03-31 | ||
| PCT/CN2022/084377 WO2023184327A1 (en) | 2022-03-31 | 2022-03-31 | Kinase inhibitors, preparation methods and uses thereof |
| CN2022118935 | 2022-09-15 | ||
| CNPCT/CN2022/118935 | 2022-09-15 | ||
| PCT/CN2023/085320 WO2023186060A1 (en) | 2022-03-31 | 2023-03-31 | Kinase inhibitors, preparation methods and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510945A JP2025510945A (ja) | 2025-04-15 |
| JP2025510945A5 true JP2025510945A5 (enExample) | 2026-03-23 |
Family
ID=88199480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557461A Pending JP2025510945A (ja) | 2022-03-31 | 2023-03-31 | キナーゼ阻害剤、その製造方法および用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250223301A1 (enExample) |
| EP (1) | EP4499640A4 (enExample) |
| JP (1) | JP2025510945A (enExample) |
| CN (1) | CN118974049A (enExample) |
| WO (1) | WO2023186060A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4486741A4 (en) | 2022-03-01 | 2026-04-08 | Insilico Medicine Ip Ltd | Diacylglycerol Kinase (DGK) Alpha Inhibitors and Their Uses |
| CN116969943A (zh) * | 2022-04-28 | 2023-10-31 | 轩竹生物科技股份有限公司 | 三并环类二酰甘油激酶抑制剂及其用途 |
| EP4661869A1 (en) | 2023-02-06 | 2025-12-17 | Bayer Aktiengesellschaft | Combinations of dgk (diacylglycerol kinase) inhibitors and immune checkpoint inhibitors and modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8536193B2 (en) * | 2008-06-03 | 2013-09-17 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| EP2729174A1 (en) * | 2011-07-08 | 2014-05-14 | Merck Sharp & Dohme Corp. | Il-23 antagonists for treatment or prevention of skin rash associated with treatment with p13k/akt pathway inhibitors |
| BR112022012204A2 (pt) * | 2019-12-23 | 2022-09-13 | Bristol Myers Squibb Co | Compostos de heteroarila substituída úteis como ativadores de célula t |
| IL294032A (en) * | 2019-12-24 | 2022-08-01 | Carna Biosciences Inc | Compounds that regulate diacylglycerol kinase |
| WO2021258010A1 (en) * | 2020-06-19 | 2021-12-23 | Gossamer Bio Services, Inc. | Oxime compounds useful as t cell activators |
| JP7686091B2 (ja) * | 2021-06-23 | 2025-05-30 | ギリアード サイエンシーズ， インコーポレイテッド | ジアシルグリセロールキナーゼ調節化合物 |
-
2023
- 2023-03-31 CN CN202380028014.1A patent/CN118974049A/zh active Pending
- 2023-03-31 WO PCT/CN2023/085320 patent/WO2023186060A1/en not_active Ceased
- 2023-03-31 EP EP23778425.1A patent/EP4499640A4/en active Pending
- 2023-03-31 JP JP2024557461A patent/JP2025510945A/ja active Pending
- 2023-03-31 US US18/852,249 patent/US20250223301A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025510945A5 (enExample) | ||
| JP6227707B2 (ja) | Ｍｃｌ‐１を調節する小分子、並びに細胞死、細胞分裂、細胞分化を調節する方法、及び疾患を治療する方法。 | |
| ES2292770T3 (es) | Derivados de fenilpirazoles en calidad de inhibidores de epoxido hidrolasa solubles. | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| JP5059275B2 (ja) | 新規３置換尿素誘導体およびその医薬としての用途 | |
| IL197135A (en) | The phenoxyphenylacetic acid derivatives are preserved in position 4, preparations containing them, their uses and methods for preparing them | |
| HRP20170638T1 (hr) | MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI | |
| RU2009115653A (ru) | Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения | |
| RU2019142795A (ru) | Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение | |
| CA2458035A1 (en) | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | |
| JP2013010792A5 (enExample) | ||
| RU2021139070A (ru) | Ингибиторы ERBB/BTK | |
| CA2415486A1 (en) | Pyramidine derivatives | |
| EA202090658A1 (ru) | Ингибиторы кэп-зависимой эндонуклеазы | |
| ES2762193T3 (es) | Agonistas de proteína tirosina fosfatasa 1 que contiene dominio de homología Src-2 y métodos de tratamiento usando la misma | |
| JP2007508362A5 (enExample) | ||
| JPWO2002014265A1 (ja) | 新規３置換尿素誘導体およびその医薬としての用途 | |
| RU2008126245A (ru) | Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции | |
| DK1786790T3 (da) | Oxazolderivater som histamin H3 receptorstoffer, fremstilling og terapeutiske anvendelser | |
| JP2019510025A5 (enExample) | ||
| RU2010115337A (ru) | Трициклические гетероциклические производные | |
| JP2024511389A5 (enExample) | ||
| RU2009102270A (ru) | Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы | |
| JP2004524345A5 (enExample) | ||
| RU2014119705A (ru) | Пиридин-сульфоксимины в качестве ингибиторов киназы |